Home
About
Overview
Sharing Data
ORCID
Help
History (108)
Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease.
Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging.
Does the presence of a dementia special care unit improve nursing home quality?
Using process elicitation and validation to understand and improve chemotherapy ordering and delivery.
The power and limitations of pharmacogenetic epidemiology.
See All 108 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The power and limitations of pharmacogenetic epidemiology.
Lapane K, Weinstock MA. The power and limitations of pharmacogenetic epidemiology. J Invest Dermatol. 2007 Aug; 127(8):1851-2.
View in:
PubMed
subject areas
Carcinoma, Squamous Cell
Clinical Trials as Topic
Glucocorticoids
Humans
Pharmacogenetics
Polymorphism, Genetic
Receptors, Glucocorticoid
Skin Neoplasms
authors with profiles
Kate L Lapane PhD